oral rigosertib
Showing 1 - 25 of >10,000
Epidermolysis Bullosa Dystrophica, Squamous Cell Carcinoma Trial in Salzburg (Rigosertib Oral Capsules / Rigosertib Intravenous)
Recruiting
- Epidermolysis Bullosa Dystrophica
- Squamous Cell Carcinoma
- Rigosertib Oral Capsules / Rigosertib Intravenous
-
Salzburg, AustriaEB House Austria/Dept. of Dermatology University Hospital
Nov 3, 2022
MDS Trial in France, Germany, United States (Oral rigosertib)
Completed
- Myelodysplastic Syndromes
- Oral rigosertib
-
Stanford, California
- +13 more
Jun 15, 2021
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral
Completed
- Myelodysplastic Syndrome
- +2 more
- oral rigosertib
- Azacitidine
-
Gilbert, Arizona
- +12 more
Jun 15, 2021
Leukemia, Myelofibrosis, Anemia Trial in Houston (Rigosertib, Questionnaire)
Terminated
- Leukemia
- +3 more
- Rigosertib
- Questionnaire
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 5, 2020
Myelodysplastic Syndrome Trial in New York (rigosertib)
Withdrawn
- Myelodysplastic Syndrome
-
New York, New YorkColumbia University Medical Center
Jun 29, 2020
Recessive Dystrophic Epidermolysis Bullosa Trial in Philadelphia (Rigosertib Sodium, Quality-of-Life Assessment)
Recruiting
- Recessive Dystrophic Epidermolysis Bullosa
- Rigosertib Sodium
- Quality-of-Life Assessment
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Aug 31, 2021
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in
Not yet recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Rigosertib
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Feb 28, 2023
Myelodysplastic Syndrome Trial in Japan (SyB C-1101 and Azacytidine)
Withdrawn
- Myelodysplastic Syndrome
- SyB C-1101 and Azacytidine
-
Nagoya, Aichi, Japan
- +3 more
Nov 14, 2022
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
NSCLC, Adenocarcinoma, Stage IV Trial in New York (Rigosertib, Nivolumab)
Recruiting
- Non-small Cell Lung Cancer
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Feb 8, 2022
Oral Ulceration Due to Behçet's Disease Trial (Rebamipide mouthwash, Betamethasone mouthwash)
Not yet recruiting
- Oral Ulceration Due to Behçet's Disease
- Rebamipide mouthwash
- Betamethasone mouthwash
- (no location specified)
Oct 13, 2023
Oral Squamous Cell Carcinoma, Oral Mucositis Trial in Guangzhou (Alfacalcidol Oral Solution, Placebo)
Recruiting
- Oral Squamous Cell Carcinoma
- Oral Mucositis
- Alfacalcidol Oral Solution
- Placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Aug 24, 2023
Oral Mucositis Trial in Istanbul (coconut oil)
Not yet recruiting
- Oral Mucositis
- coconut oil
-
Istanbul, TurkeyBaşakşehir Çam and Sakura City Hospital
May 8, 2023
Prophylactic Oral Vitamin D and Zinc for Radiation-Induced Oral
Not yet recruiting
- Oncology
- Vitamin D
- (no location specified)
Oct 20, 2023
Breathing, Mouth, Pneumonia, Frailty Trial in Tainan City (Oral exercises and oral hygiene, Oral care)
Recruiting
- Breathing, Mouth
- +2 more
- Oral exercises and oral hygiene
- Oral care
-
Tainan City, TaiwanNational Cheng Kung University Hospital, College of Medicine, Na
Aug 13, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Sumida City (CCX168, Placebo)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- CCX168
- Placebo
-
Sumida City, Tokyo, JapanSumida Hospital, SOUSEIKAI Global Clinical Research Center
Aug 4, 2023
Mucositis Oral Trial in Izmir (oral self care protocol, standard care)
Completed
- Mucositis Oral
- oral self care protocol
- standard care
-
İzmir, Bornova, TurkeyEge University Medical Faculty Hospital
Sep 21, 2023
Oral Microbiome Health Trial in Bothell (VRx MyBiotics Oral Lozenges)
Recruiting
- Oral Microbiome Health
- VRx MyBiotics Oral Lozenges
-
Bothell, WashingtonViome Life Sciences
Jul 24, 2023
H. Pylori Infection Trial in Shanghai (MAXPOWER Biological Antibacterial Liquid, Water)
Recruiting
- H. Pylori Infection
- MAXPOWER Biological Antibacterial Liquid
- Water
-
Shanghai, Shanghai, ChinaChanghai hospital
Sep 13, 2023
Gingivitis Trial in Kuala Lumpur (Brush DJ app)
Active, not recruiting
- Gingivitis
- Brush DJ app
-
Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, MalaysiaIRDI
May 2, 2023
Oral Health, Prisoners Trial in Sandnes (Motivational Interviewing)
Recruiting
- Oral Health
- Prisoners
- Motivational Interviewing
-
Sandnes, NorwayNorwegian Correctional Service
Jan 12, 2023
People Living With HIV, Oral and Oropharyngeal Cancer, and
Not yet recruiting
- HIV Infections
- +2 more
- Group Meeting (Focus Group)
- Questionnaires
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 20, 2023
Oral Mucositis Trial in Roma (Zinc Gluconate, Sodium Bicarbonate)
Recruiting
- Oral Mucositis
- Zinc Gluconate
- Sodium Bicarbonate
-
Roma, ItalyCatholic University of the Sacred Hearth
May 8, 2023